{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T18:29:01Z","timestamp":1776104941549,"version":"3.50.1"},"reference-count":47,"publisher":"ALUNA","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Wiad Lek"],"published-print":{"date-parts":[[2022,11]]},"abstract":"<jats:p>The aim: The purpose of this research was to find out the effect of Methylsulfonylmethane in minimizing hair loss. \nMaterials and methods: Twenty adult Wister Albino mice weighing 25-35g and aged 6-7 weeks were employed. Male mice\u2019s coat hairs on the dorsal skin were carefully clipped and then colored. Mice were randomly assigned into four groups, each with five animals: (1) Control group: Treated with D.W. (2), Minoxidil (5%) treated group (3), Methylsulfonylmethane (10%) treated group (4), Methylsulfonylmethane plus Minoxidil treated group. \nResults: We found that the tissue level of 8-isoprastanein the groups receiving medication are considerably lower than in the control (D.W.). We also discovered that the serum tissue vascular endothelial growth factor levels in the groups receiving medication are considerably greater than those in the control (D.W.) groups. On the other hand, we discovered that hair growth, hair follicle expansion and hair follicle number are much higher in the groups receiving medication than in the control groups. \nConclusions: We concluded that MSM, through its antioxidant and anti-inflammatory properties, dramatically reduces hair loss in male mice.<\/jats:p>","DOI":"10.36740\/wlek202211206","type":"journal-article","created":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T21:19:29Z","timestamp":1672607969000},"page":"2744-2751","source":"Crossref","is-referenced-by-count":2,"title":["EVALUATION OF THE EFFECT OF TOPICALLY APPLIED METHYLSULFONYLMETHANE AND THEIR COMBINATION WITH MINOXIDIL SOLUTION FOR IMPROVEMENT OF HAIR GROWTH IN MALE MICE"],"prefix":"10.36740","volume":"75","author":[{"given":"Ammar A.","family":"Hummadi","sequence":"first","affiliation":[{"name":"DEPARTMENT OF PHARMACOLOGY AND THERAPEUTICS, FACULTY OF MEDICINE, KUFA UNIVERSITY, NAJAF, IRAQ"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarmad N.","family":"Gany","sequence":"additional","affiliation":[{"name":"DEPARTMENT OF PHARMACOLOGY AND THERAPEUTICS, FACULTY OF MEDICINE, KUFA UNIVERSITY, NAJAF, IRAQ"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Najah R.","family":"Hadi","sequence":"additional","affiliation":[{"name":"DEPARTMENT OF PHARMACOLOGY AND THERAPEUTICS, FACULTY OF MEDICINE, KUFA UNIVERSITY, NAJAF, IRAQ"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"22436","published-online":{"date-parts":[[2022]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","unstructured":"1. Mubki T, Rudnicka L, Olszewska M, Shapiro J. Evaluation and diagnosis of the hair loss patient: Part I. History and clinical examination. J Am Acad Dermatol. 2014;71(3):415.e1-415.e15. doi: 10.1016\/j.jaad.2014.04.070","DOI":"10.1016\/j.jaad.2014.04.070"},{"key":"ref1","doi-asserted-by":"publisher","unstructured":"2. Santos Z, Avci P, Hamblin MR. Drug discovery for alopecia: gone today, hair tomorrow. Expert Opin. Drug Discov. 2015;10(3):269. doi: 10.1517\/17460441.2015.1009892","DOI":"10.1517\/17460441.2015.1009892"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"3. Or\u0103san MS, Coneac A. Evaluation of Animal Models Suitable for Hair Research and Regeneration. Exp. Anim. Model. Hum. Dis. An Eff. Ther Strateg. 2017 IntecOpen; doi: 10.5772\/intechopen.69698","DOI":"10.5772\/intechopen.69698"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"4. Goodheart HP. Goodheart\u2019s photoguide to common skin disorders : diagnosis and management. Philadelphia : Lippincott Williams & Wilkins, 2009; p. 556","DOI":"10.1001\/jama.2009.882"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"5. Wolff H, Fischer TW, Blume-Peytavi U. The Diagnosis and Treatment of Hair and Scalp Diseases. Dtsch. Arztebl. Int. 2016; 113(21):377-386. doi: 10.3238\/ARZTEBL.2016.0377","DOI":"10.3238\/arztebl.2016.0377"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"6. Nalluri R, Harries M. Alopecia in general medicine. Clin Med (Northfield. Il). 2016;16(1):74. doi: 10.7861\/clinmedicine.16-1-74","DOI":"10.7861\/clinmedicine.16-1-74"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"7. Vary JC. Selected Disorders of Skin Appendages-Acne, Alopecia, Hyperhidrosis. Med Clin North Am. 2015;99(6):1195-1211. doi: 10.1016\/J.MCNA.2015.07.003","DOI":"10.1016\/j.mcna.2015.07.003"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"8. Harrison S, Sinclair R. Telogen effluvium. Clin Exp Dermatol. 2002;27(5):389-395. doi: 10.1046\/J.1365-2230.2002.01080.X","DOI":"10.1046\/j.1365-2230.2002.01080.x"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"9. Grover C, Khurana A. Telogen effluvium. Indian J Dermatol Venereol Leprol. 2013;79(5):591-603. doi: 10.4103\/0378-6323.116731","DOI":"10.4103\/0378-6323.116731"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"10. Al-Refu K. Hair loss in children: common and uncommon causes; clinical and epidemiological study in Jordan. Int J Trichology. 2013;5(4):185- 189. doi: 10.4103\/0974-7753.130393","DOI":"10.4103\/0974-7753.130393"},{"key":"ref10","unstructured":"11. Hughes EC, Saleh D. Telogen Effluvium. StatPearls. 2021; https:\/\/www. ncbi.nlm.nih.gov\/books\/NBK430848\/ [Access: February 2022]"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"12. Harrison S, Bergfeld W. Diffuse hair loss: Its triggers and management. Cleve Clin J Med. 2009;76(6):361-367. doi: 10.3949\/CCJM.76A.08080","DOI":"10.3949\/ccjm.76a.08080"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"13. Rossi A, Cantisani C, Melis L, et al. Minoxidil use in dermatology, side effects and recent patents. Recent Pat. Inflamm. Allergy Drug Discov. 2012;6(2):130-136. doi: 10.2174\/187221312800166859","DOI":"10.2174\/187221312800166859"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"14. Garg S, Manchanda S. Platelet-rich plasma-an Elixir for treatment of alopecia: personal experience on 117 patients with review of literature. Stem Cell Investig. 2017;4(7):64. doi: 10.21037\/SCI.2017.06.07","DOI":"10.21037\/sci.2017.06.07"},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"15. Burns LJ, De Souza B, Flynn E, Hagigeorges D, Senna MM. Spironolactone for treatment of female pattern hair loss. J Am Acad Dermatol. 2020;83(1):276-278. doi: 10.1016\/J.JAAD.2020.03.087","DOI":"10.1016\/j.jaad.2020.03.087"},{"key":"ref15","unstructured":"16. Amirchaghmaghi M et al. Evaluation of Plasma Isoprostane in Patients with Oral Lichen Planus. J Dent. 2022;17(1):21."},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"17. van\u2019t Erve TJ, MB, Kadiiska SJ, Mason RP. Classifying oxidative stress by F2-isoprostane levels across human diseases: A meta-analysis. Redox Biol. 2017;12:582-599, doi: 10.1016\/J.REDOX.2017.03.024","DOI":"10.1016\/j.redox.2017.03.024"},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"18. Belli R, Amerio P, Brunetti L, et al. Elevated 8-isoprostane levels in basal cell carcinoma and in UVA irradiated skin. Int J Immunopathol Pharmacol. 2005;18(3):497-502, doi: 10.1177\/039463200501800309","DOI":"10.1177\/039463200501800309"},{"key":"ref18","doi-asserted-by":"publisher","unstructured":"19. Esmaeeli S, Hoseinirad SM, Rajabian M, et al. Evaluation of the oxidant-antioxidant balance, isoprostane and quantitative CRP in patients with cutaneous leishmaniasis. Microb Pathog. 2019;137:103738. doi: 10.1016\/J.MICPATH.2019.103738","DOI":"10.1016\/j.micpath.2019.103738"},{"key":"ref19","doi-asserted-by":"publisher","unstructured":"20. Holmes H, Roberts OL, Thomas A,Cross MJ. Vascular endothelial growth factor receptor-2: structure, function, intracellular signalling and therapeutic inhibition. Cell Signal. 2003;19(10):2003-12. doi: 10.1016\/j. cellsig.2007.05.013","DOI":"10.1016\/j.cellsig.2007.05.013"},{"key":"ref20","doi-asserted-by":"publisher","unstructured":"21. Alexandrescu DT, Kauffman CL, Dasanu CA. The cutaneous epidermal growth factor network: Can it be translated clinically to stimulate hair growth? Dermatol Online J. 2009;15(3). doi: 10.5070\/ D39T44R88S","DOI":"10.5070\/d39t44r88s"},{"key":"ref21","doi-asserted-by":"publisher","unstructured":"22. Yun YR, et al. Fibroblast Growth Factors: Biology, Function, and Application for Tissue Regeneration. Journal of Tissue Engineering. 2010;1(1):1-18, doi.org\/10.4061\/2010\/218142","DOI":"10.4061\/2010\/218142"},{"key":"ref22","doi-asserted-by":"publisher","unstructured":"23. Zhao J, Harada N, Okajima K. Dihydrotestosterone inhibits hair growth in mice by inhibiting insulin-like growth factor-I production in dermal papillae. Growth Horm IGF Res. 2011;21(5):260-267, doi: 10.1016\/J. GHIR.2011.07.003","DOI":"10.1016\/j.ghir.2011.07.003"},{"key":"ref23","doi-asserted-by":"publisher","unstructured":"24. Li W, et al. VEGF upregulates VEGF receptor-2 on human outer root sheath cells and stimulates proliferation through ERK pathway. Mol Biol Reports. 2012;39(9):8687-8694. doi: 10.1007\/S11033-012-1725-6","DOI":"10.1007\/s11033-012-1725-6"},{"key":"#cr-split#-ref24.1","unstructured":"25. Spanish N, Agency for Consumer Affairs. Report of the Scientific Committee of the Spanish Agency for Consumer Affairs, Food Safety and Nutrition (AECOSAN) on the conditions of use of certain substances to be used in food supplements-3. 2014"},{"key":"#cr-split#-ref24.2","unstructured":"https:\/\/www.aesan.gob.es\/ AECOSAN\/docs\/documentos\/seguridad_alimentaria\/evaluacion_ riesgos\/informes_cc_ingles\/FOOD_SUPPLEMENTS-5.pdf [Access: April 2022]. doi: 10.5281\/ZENODO.808424"},{"key":"ref25","doi-asserted-by":"publisher","unstructured":"26. Crawford P, Crawford A, Nielson F, Lystrup R. Methylsulfonylmethane for treatment of low back pain: A safety analysis of a randomized, controlled trial. Complement. Ther. Med. 2019; 45: 85-88. doi: 10.1016\/J. CTIM.2019.05.022","DOI":"10.1016\/j.ctim.2019.05.022"},{"key":"ref26","unstructured":"27. Hansen PL, T\u00f8nnig K, Pommer K, Malmgren B, Hansen OC, Poulsen M. Survey and health risk assessment of products for treatment of sports injuries and pains. Danish Ministry of Environment, 2006. https:\/\/ www2.mst.dk\/Udgiv\/publications\/2006\/87-7052-318-5\/pdf\/87-7052- 319-3.pdf [Access April 2022]"},{"key":"ref27","doi-asserted-by":"publisher","unstructured":"28. He X, Slupsky SM. Metabolic fingerprint of dimethyl sulfone (DMSO2) in microbial-mammalian co-metabolism. J Proteome Res. 2014;13(12): 5281-5292. doi: 10.1021\/PR500629T","DOI":"10.1021\/pr500629t"},{"key":"ref28","unstructured":"29. Gregory PJ, Sperry M, Wilson AF. Dietary Supplements for Osteoarthritis. Am. Fam. Physician. 2008; 77(2): 177-184."},{"key":"ref29","doi-asserted-by":"publisher","unstructured":"30. Mar\u00e3n G, et al. The effect of methyl sulphonyl methane supplementation on biomarkers of oxidative stress in sport horses following jumping exercise. Acta Vet Scand. 2008;50(1):1-9. doi: 10.1186\/1751-0147-50- 45\/FIGURES\/4","DOI":"10.1186\/1751-0147-50-45"},{"key":"ref30","doi-asserted-by":"publisher","unstructured":"31. Kim YH, Kim DH, Lim H, Baek DY, Shin HK, Kim JK. The anti-inflammatory effects of methylsulfonylmethane on lipopolysaccharide-induced inflammatory responses in murine macrophages. Biol. Pharm. Bull. 2009;32(4):651-656. doi: 10.1248\/BPB.32.651","DOI":"10.1248\/bpb.32.651"},{"key":"ref31","doi-asserted-by":"publisher","unstructured":"32. Mohammadi S, et al. Protective effects of methylsulfonylmethane on hemodynamics and oxidative stress in monocrotaline-induced pulmonary hypertensive rats. Adv Pharmacol Sci. 2012;2012:507278. doi: 10.1155\/2012\/507278","DOI":"10.1155\/2012\/507278"},{"key":"ref32","doi-asserted-by":"publisher","unstructured":"33. Barrager E, Veltmann JR Jr, Schauss AG, Schiller RN. Sulfur in human nutrition and applications in medicine. A multicentered, open-label trial on the safety and efficacy of methylsulfonylmethane in the treatment of seasonal allergic rhinitis. J Altern Complement Med. 2002;7(1):167-73.","DOI":"10.1089\/107555302317371451"},{"key":"ref33","doi-asserted-by":"publisher","unstructured":"34. Joung YH, et al. Methylsulfonylmethane Inhibits RANKL-Induced Osteoclastogenesis in BMMs by Suppressing NF-\u03baB and STAT3 Activities. PLoS One. 2016;11(7), doi: 10.1371\/JOURNAL.PONE.0159891","DOI":"10.1371\/journal.pone.0159891"},{"key":"ref34","doi-asserted-by":"publisher","unstructured":"35. Lawrence T. The nuclear factor NF-kappaB pathway in inflammation. Cold Spring Harb Perspect Biol. 2009;1(6). doi: 10.1101\/CSHPERSPECT. A001651","DOI":"10.1101\/cshperspect.a001651"},{"key":"ref35","doi-asserted-by":"publisher","unstructured":"36. Ahn H, Kim J, Lee MJ, Kim YJ, Cho YW, Lee GS. Methylsulfonylmethane inhibits NLRP3 inflammasome activation. Cytokine. 2015;71(2):223- 231. doi: 10.1016\/J.CYTO.2014.11.001","DOI":"10.1016\/j.cyto.2014.11.001"},{"key":"ref36","doi-asserted-by":"publisher","unstructured":"37. Coleman JW. Nitric oxide: a regulator of mast cell activation and mast cell-mediated inflammation. Clin. Exp. Immunol. 2002;129(1):4-10. doi: 10.1046\/J.1365-2249.2002.01918.X","DOI":"10.1046\/j.1365-2249.2002.01918.x"},{"key":"ref37","doi-asserted-by":"publisher","unstructured":"38. Tousoulis D, Kampoli AM, Tentolouris C, Stefanadis C. The role of nitric oxide on endothelial function. Curr Vasc Pharmacol. 2012;10(1):4-18. doi: 10.2174\/157016112798829760","DOI":"10.2174\/157016112798829760"},{"key":"ref38","doi-asserted-by":"publisher","unstructured":"39. Hoffmann R. TrichoScan: a novel tool for the analysis of hair growth in vivo. J Investig. dermatology. Symp Proc. 2003;8(1):109-115. doi: 10.1046\/J.1523-1747.2003.12183.X","DOI":"10.1046\/j.1523-1747.2003.12183.x"},{"key":"ref39","doi-asserted-by":"publisher","unstructured":"40. Aldhalimi MA, Hadi NR, Ghafil FA. Promotive Effect of Topical Ketoconazole, Minoxidil, and Minoxidil with Tretinoin on Hair Growth in Male Mice. ISRN Pharmacol. 2014 Mar 9;2014:575423. doi: 10.1155\/2014\/575423","DOI":"10.1155\/2014\/575423"},{"key":"ref40","doi-asserted-by":"publisher","unstructured":"41. Li W, et al. Shikonin Suppresses Skin Carcinogenesis via Inhibiting Cell Proliferation. PLoS One. 2015; 10(5). doi: 10.1371\/JOURNAL. PONE.0126459","DOI":"10.1371\/journal.pone.0126459"},{"key":"ref41","doi-asserted-by":"publisher","unstructured":"42. Alboreadi MA, Al-Najdawi MM, Jarrar QB, Moshawih S. Evaluation of hair growth properties of Topical Kombucha tea extracts. Adv. Tradit. Med. 2021;22(1):155-161. doi: 10.1007\/S13596-020-00534-7","DOI":"10.1007\/s13596-020-00534-7"},{"key":"ref42","doi-asserted-by":"publisher","unstructured":"43. Shanmugam S, et al. The effect of methylsulfonylmethane on hair growth promotion of magnesium ascorbyl phosphate for the treatment of alopecia. Biomol Ther. 2009;17(3):241-248, doi: 10.4062\/ BIOMOLTHER.2009.17.3.241","DOI":"10.4062\/biomolther.2009.17.3.241"},{"key":"ref43","doi-asserted-by":"publisher","unstructured":"44. Lim EJ, et al. Methylsulfonylmethane Suppresses Breast Cancer Growth by Down-Regulating STAT3 and STAT5b Pathways. PLoS One. 2012;7(4): e33361. doi: 10.1371\/JOURNAL.PONE.0033361","DOI":"10.1371\/journal.pone.0033361"},{"key":"ref44","doi-asserted-by":"crossref","unstructured":"45. Niu G, et al. Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesis. Oncogene. 2002;21(13):2000-2008. doi: 10.1038\/ sj.onc.1205260","DOI":"10.1038\/sj.onc.1205260"},{"key":"ref45","doi-asserted-by":"publisher","unstructured":"46. Amirshahrokhi K, Bohlooli S. Effect of methylsulfonylmethane on paraquat-induced acute lung and liver injury in mice. Inflammation 2013; 36(5): 1111-1121, doi: 10.1007\/S10753-013-9645-8","DOI":"10.1007\/s10753-013-9645-8"}],"container-title":["Wiadomo\u015bci Lekarskie"],"original-title":[],"language":"en","deposited":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T21:19:46Z","timestamp":1672607986000},"score":1,"resource":{"primary":{"URL":"https:\/\/wiadlek.pl\/wp-content\/uploads\/archive\/2022\/10\/WLek202211206.pdf"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022]]},"references-count":47,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2022]]},"published-print":{"date-parts":[[2022,11]]}},"URL":"https:\/\/doi.org\/10.36740\/wlek202211206","archive":["Internet Archive"],"relation":{},"ISSN":["0043-5147"],"issn-type":[{"value":"0043-5147","type":"print"}],"subject":[],"published":{"date-parts":[[2022]]}}}